Jul 1, 2026 01:00AM
May 22, 2026 12:25PM
May 22, 2026 12:25PM
Apr 23, 2026 01:00AM
Mar 5, 2026 01:00AM
Feb 27, 2026 01:00AM
Feb 25, 2026 01:00AM Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of Injectable Aesthetics
Feb 2, 2026 01:00AM
Dec 17, 2025 01:00AM
Dec 11, 2025 01:00AM
Nov 17, 2025 01:00AM
Nov 5, 2025 01:01AM
Nov 5, 2025 01:00AM
Oct 23, 2025 01:00AM Galderma Delivers Record Net Sales of 3.737 Billion USD in the First Nine Months of 2025 and 15.0% Year-on-Year Growth at Constant Currency, Raises Full-Year Guidance
Sep 11, 2025 01:00AM
Jun 25, 2025 01:00AM
Jun 18, 2025 01:00AM
Jun 6, 2025 01:00AM
Apr 22, 2025 06:00AM
Mar 17, 2025 08:00AM
Mar 6, 2025 01:00AM Galderma Delivers 2024 Record Net Sales of 4.410 Billion USD, up 9.3% Year-on-Year at Constant Currency¹, and Record Core EBITDA of 1.031 Billion USD, While Preparing to Accelerate Its Growth Traject
Mar 3, 2025 01:00AM
Feb 14, 2025 01:00AM
Dec 13, 2024 05:09PM
Dec 13, 2024 01:00AM
Nov 28, 2024 01:00AM
Oct 24, 2024 01:00AM
Sep 25, 2024 01:00AM EADV 2024 Late Breaking News Sessions: New Galderma Data Demonstrating Nemolizumab’s Long-term Efficacy and Safety in Atopic Dermatitis and Durability in Prurigo Nodularis to Be Shared During Three
Aug 13, 2024 01:01AM
Jul 25, 2024 12:30AM
May 7, 2024 01:00AM
Apr 24, 2024 01:00AM

324,678 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All